Beijing, China

Dawei Tan

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dawei Tan: Innovator in Stroke Prevention and Treatment

Introduction

Dawei Tan is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medicine, particularly in the prevention and treatment of stroke. His innovative work has garnered attention for its potential impact on neurological health.

Latest Patents

Dawei Tan holds a patent for the use of timosaponin BII in the preparation of a medicament or product for the prevention and treatment of stroke. This invention demonstrates that timosaponin BII can improve neurological symptoms in cerebral ischemic rats, reduce infarct size, relieve brain water edema, enhance hemorheology, and mitigate inflammatory injury associated with cerebral ischemia. His patent is a testament to his dedication to advancing medical science.

Career Highlights

Tan is affiliated with the Institute of Radiation Medicine, Academy of Military Medical Sciences, PLA. His work at this esteemed institution has allowed him to focus on critical research that addresses significant health challenges. His contributions have been instrumental in developing new therapeutic approaches for stroke.

Collaborations

Dawei Tan has collaborated with notable colleagues, including Baiping Ma and Quiping Xu. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in the medical field.

Conclusion

Dawei Tan's innovative work in stroke prevention and treatment exemplifies the importance of research and development in medicine. His contributions are paving the way for new therapeutic options that could significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…